Samsung Biologics announces all-cash offer to acquire PolyPeptide for CHF 1.46 billion, expanding global network across U.S., Europe, and India
On Jul. 19, 2026, Samsung Biologics announced the launch of an all-cash public tender offer to acquire 100%…